First Patient Dosed in Chemotherapy Induced Peripheral Neuropathy Clinical Trial

Contributed by: PR Newswire

Tags

Ananda-Pharma-1-Trial

More Like This

MRX1 Successfully Delivered to Clinical Trial Site

Phase 1 MRX1 Study Delivers Strong Headline Data

ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis

Business Wire logo

Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy

(Photo: Business Wire)

ANANDA Scientific Announces a Clinical Trial Evaluating Nantheia™ ATL5, in the treatment of Co-Occurring Opioid Use Disorder and Chronic Pain

Business Wire logo

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

Peer-reviewed Publication Shows that Lateral Pharma's SCP Drugs for Neuropathic Pain Act Via the Novel Target LanCL1

Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair